bexotegrast   Click here for help

GtoPdb Ligand ID: 12108

Synonyms: PLN-74809 | PLN74809
Compound class: Synthetic organic
Comment: Bexotegrast (PLN-74809; Pliant Therapeutics) is a dual-selective integrin inhibitor/antagonist that was developed for anti-fibrosis potential [1]. The αv integrins regulate TGFβ activation (catalysing conversion of latent TGFβ isoforms to the active forms) and fibrogenesis in pulmonary fibrosis models [2-3], and αvβ6 and αvβ1 integrins are expressed on abnormal epithelial cells and fibroblasts (respectively) in human fibrotic lung tissue. By antagonising the function of both of these, bexotegrast restricts TGFβ activation and downstream signalling, which has been shown to promote an anti-fibrogenic effect in lung tissue samples from patients with idiopathic pulmonary fibrosis (IPF) [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 3
Rotatable bonds 14
Topological polar surface area 112.5
Molecular weight 492.28
XLogP 0.8
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COCCN(CC[C@@H](C(=O)O)Nc1ncnc2c1cccc2)CCCCc1ccc2c(n1)NCCC2
Isomeric SMILES COCCN(CCCCc1nc2c(CCCN2)cc1)CC[C@@H](C(=O)O)Nc1ncnc2ccccc12
InChI InChI=1S/C27H36N6O3/c1-36-18-17-33(15-5-4-8-21-12-11-20-7-6-14-28-25(20)31-21)16-13-24(27(34)35)32-26-22-9-2-3-10-23(22)29-19-30-26/h2-3,9-12,19,24H,4-8,13-18H2,1H3,(H,28,31)(H,34,35)(H,29,30,32)/t24-/m0/s1
InChI Key CWOFQJBATWQSHL-DEOSSOPVSA-N
Bioactivity Comments
Bexotegrast (PLN-74809) exhibits ≥ 445-fold selectivity for αvβ1vβ 6 integrins compared to other αv-containing integrins [1].
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
integrin, alpha V subunit Hs Antagonist Antagonist 5.5 pIC50 - 1
pIC50 5.5 (IC50 3.4x10-6 M) [1]
Description: Determined in a human αVβ1 ligand binding assay